Q3 2025 Earnings Call Transcript October 29, 2025 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is ...

Discover Q3 2025 highlights for Emergent BioSolutions: raised revenue guidance, strong naloxone sales, and margin growth.

Emergent Biosolutions ( (EBS) ) has shared an announcement. On October 29, 2025, Emergent BioSolutions reported its financial results for the third quarter of 2025, with total revenues of $231.1 ...

CME Group, the world's leading derivatives marketplace, today announced that its metals complex volume reached a record 2,829,666 contracts on Friday, October 17, 2025. The new high overtakes the ...

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.

The Clop ransomware gang has been exploiting a critical Oracle E-Business Suite (EBS) zero-day bug in data theft attacks since at least early August, according to cybersecurity company CrowdStrike.

Oracle E-Business Suite (EBS) customers have been urged to patch a critical vulnerability in the product, after reports that the notorious Clop ransomware group has exploited the bug in attacks as a ...

Update 10/6/25 11:15 AM ET: Updated story with more information on the leaked Oracle source code and the leaking of the exploit. Oracle is warning about a critical E-Business Suite zero-day ...